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AbstrACt
Objective Cardiac disease in pregnancy is a leading 
cause of maternal death in high-income countries. 
Evidence-based guidelines to assist in planning and 
managing the healthcare of affected women is lacking. 
The objective of this research was to produce the first 
qualitative metasynthesis of the experiences of pregnant 
women with existing or acquired cardiac disease to inform 
improved healthcare services.
Method We conducted a systematic search of peer-
reviewed publications in five databases to investigate 
the decision-making processes, supportive strategies 
and healthcare experiences of pregnant women with 
existing or acquired cardiac disease, or of affected women 
contemplating pregnancy. Identified publications were 
screened for duplication and eligibility against selection 
criteria, following Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses guidelines. We then undertook 
a thematic analysis of the data relating to women’s 
experiences extracted from each publication to inform new 
healthcare practices and communication.
results Eleven studies from six countries were included 
in our meta-synthesis. Four themes were revealed. 
Women with congenital and acquired heart disease 
identified situations where they had either taken charge of 
decision-making, lacked control or experienced emotional 
uncertainty when making decisions. Some women were 
risk aware and determined to take care of themselves in 
pregnancy while others downplayed the risks. Women with 
heart disease acknowledged the importance of specific 
social support measures during pregnancy and after child 
birth, and reported a spectrum of healthcare experiences.
Conclusions There is a lack of integrated and tailored 
healthcare services and information for women with cardiac 
disease in pregnancy. The experiences of women synthesised 
in this research has the potential to inform new evidence-
based guidelines to support the decision-making needs of 
women with cardiac disease in pregnancy. Shared decision-
making must consider communication across the clinical 
team. However, coordinated care is challenging due to the 
different specialists involved and the limited clinical evidence 
concerning effective approaches to managing such complex 
care.
IntrOduCtIOn 
Cardiac disease in pregnancy is a leading 
cause of maternal death in the developed 
world. In the USA, pregnancy-related deaths 
due to cardiovascular disease were ranked 
as the leading category of death from 2011 
to 2013 at 15.5%.1 In the UK, the rate of 
maternal deaths associated with cardiac 
disease more than doubled from 1.0 in 1985 
to 2.3 per 1 00 000 maternities in 2008.2 In 
Australia, cardiac disease in pregnancy has 
been the leading cause of indirect maternal 
deaths for almost 50 years,3 4 and a common 
cause of late maternal death.4 5 
Cardiac disease in pregnancy constitutes 
a broad spectrum of conditions, including 
congenital heart diseases (eg, ventricular septal 
defect, transposition of the great vessels), 
genetic heart diseases (eg, hypertrophic 
cardiomyopathy, long QT syndrome, Brugada 
syndrome), chronic arrhythmia conditions 
(eg, Wolff-Parkinson-White syndrome), as well 
as heart diseases acquired before or during 
pregnancy (eg, rheumatic heart disease, isch-
aemic heart disease, peripartum cardiomyop-
athy (PPCM)). Heart transplants can also affect 
pregnancy outcomes.
Cardiac disease in pregnancy is associated 
with high rates of morbidity and hospitalisa-
tion. For example, 15% of women in Europe 
have been admitted for cardiac indications 
strengths and limitations of this study
 ► This is the first metasynthesis of qualitative research 
that investigated the experiences of pregnant wom-
en with a spectrum of cardiac disease.
 ► The small number of studies in this synthesis 
demonstrated the paucity of qualitative research in 
this area, particularly the voices of pregnant women 
with genetic conditions.
 ► The thematic analysis enabled patterns to be dis-
cerned that could be translated to cardiac disease 
in pregnancy and potentially other rare and chronic 
diseases in pregnancy.
 ► Our multidisciplinary research team enabled a rich 
and detailed yet complex account of the extracted 
data.
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during pregnancy.6 Approximately one in four women with 
cardiac disease in pregnancy are hospitalised during preg-
nancy, and overall cardiac disease in pregnancy is associ-
ated with the increased likelihood of eclampsia, caesarean 
birth and postpartum haemorrhage.6 For the baby, there 
is an increased likelihood of stillbirth, preterm birth and 
acquired congenital disease.6 The European Registry of 
Pregnancy and Cardiac Disease has reported significant 
adverse perinatal outcomes for both mother and baby, most 
notably a maternal mortality rate of 1%, which is more than 
100 times the rate for women without cardiac disease.
Confidential death enquiry data from the UK suggest 
there are an increasing number of women who die from 
the combination of pregnancy and cardiac disease.2 
There are several possible explanations for this observa-
tion, including the improved survival (~90%) of children 
with congenital heart disease to adulthood, increased 
awareness and diagnosis of genetic conditions, lifestyle 
factors (eg, obesity) and older maternal age associated 
with ischaemic heart disease.7–9
Many women with cardiac disease have been found 
to have high rates of unintended pregnancies that may 
reflect the availability and acceptability of and access to 
pre-conception and pregnancy counselling by healthcare 
professionals, as well as gaps in women’s contraceptive 
knowledge and decision making support.10 11 Despite 
clinical available guidelines,12–14 limited knowledge exists 
regarding the healthcare, support and decision-making 
experiences of women with cardiac disease who are preg-
nant, or contemplating pregnancy. Insights into women’s 
experiences of planning and undergoing pregnancy 
including their perceptions and satisfaction are critical 
to the provision of health services, care and information.
This paper aims to synthesise qualitative healthcare 
evidence to deliver new insights to best support deci-
sion-making for women with cardiac disease and for health-
care professionals to improve their quality of cardiac care 
from preconception planning to the postnatal period.
MethOds
data sources and search strategy
We undertook a qualitative systematic review of the liter-
ature and conducted a meta-analysis following methods 
outlined by Thomas and Harden15 to understand the 
healthcare experiences of pregnant women or women 
contemplating pregnancy with existing or acquired 
cardiac disease, in order to gain insights into their resil-
ience including coping strategies.
We used the Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses statement (figure 1) with a 
cut-off date of 2016. We searched the literature available 
in five online, bibliographic databases: CINAHL Plus 
(1995–October 2016), Embase (1996–October 2016), 
Ovid MEDLINE (1996–October2016), PsycINFO (1984–
October 2016) and the Joanna Briggs Institute Evidence 
Based Practice Database (1996–October 2016). Boolean 
operators (and, or, not) were used to refine our search 
with the following keywords: cardiac disease, pregnancy, 
pregnant women, decision-making and shared deci-
sion-making. Publications that met our selection criteria 
(table 1) were further analysed. We also searched for 
publications in Google Scholar and manually from the 
reference lists of key papers that identified an additional 
19 relevant publications. See online supplementary 
appendix for details of the bibliographic search strategy.
Quality assessment and data extraction
Nineteen potentially relevant publications were iden-
tified. Of these, eight were excluded because they were 
either irrelevant or not peer-reviewed (eg, PhD thesis). 
Six qualitative publications and the qualitative compo-
nents of five mixed methods publications were appraised 
using the Critical Appraisal Skills Programme (CASP) 
qualitative checklist16 by two authors (AD and YK). Each 
paper was independently assessed using a table with 10 
CASP questions that analysed the data sampling, collec-
tion and analysis processes and the coherence of the para-
digm underpinning the study involving the fit between 
the data gathered and the conceptual work of analysis 
and interpretation. Despite the methodological limita-
tions of some papers, including gaps in the discussion of 
reflexivity and credibility, all 11 papers were included in 
the metasynthesis as it was deemed that their strengths 
outweighed these issues. Data from the findings sections 
of each publication that detailed the preconception plan-
ning and pregnancy experiences of women with cardiac 
disease were extracted for further analysis. This included 
direct quotes and text describing related findings.
data analysis
The extracted text was coded 'line-by-line' by two authors 
(AD and YK) and then descriptive categories were devel-
oped that aligned with the original studies. The concepts 
from the descriptive categories were grouped into themes 
and subthemes and conceptual links among themes were 
identified. Tables were used for this process. Emerging 
descriptor texts were highlighted in different colours in 
each study in each paper. These descriptors were then 
compared across papers and similar descriptors were 
synthesised into one table. This led to the conflation of 
descriptive themes and the development of emergent 
categories whose meaning was refined in order to answer 
the research questions and address the aim of the study.17
Patient and public involvement
Qualitative patient data were the focus of this synthesis; 
however, patients and the public were not involved in the 
design of the study or analysis of the data.
results
A summary of the methodology and findings of the 
11 studies used in this study is given in table 2. The 
studies were conducted across six countries: USA (n=5), 
Australia (n=2), Sweden, (n=2), Canada (n=1), Norway 
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(n=1) and Belgium (n=1). Six studies comprised quali-
tative designs18–23 and five used mixed methods24–28 (see 
table 3). There were a total of 383 women participants 
with the following conditions: congenital heart disease 
(n=81), PPCM (n=298) and long QT syndrome (see 
table 3; n=4).
Four themes and seven subthemes emerged from our 
meta-analysis and are summarised in table 4 and described 
in more detail below.
Women’s autonomy and control
Taking charge of decision-making
Some women expressed their determination to take 
control and make their own decisions regarding their 
pregnancies. One woman was resolute to try to fall 
pregnant and if unsuccessful wanted to consider other 
options: ‘l want to give birth to at least one child. l want 
to have the opportunity to do that, then later I can adopt 
…’.18 Another woman became pregnant 2 months after 
her diagnosis of heart disease and described being ‘told 
to terminate her pregnancy’ but she ‘refused’.27 Another 
woman felt she ‘had lived a good life’ and her disease 
‘could not be considered a reason for terminating a preg-
nancy’.18 The positive thinking that ‘life isn’t over just 
because you have peripartum cardiomyopathy’ and the 
possibility of having more children was a key factor driving 
the decision of women who went through another preg-
nancy and ‘received a beautiful little girl in exchange’.26
The trust that women had in their clinicians and their 
experiences of successfully adapting to their congenital 
cardiac disease by developing coping mechanisms played 
a role in their desire to make their own decisions and 
proceed with their pregnancies.25 Some women felt that 
they had to take responsibility not only for their own 
health, but also for that of future generations. These 
Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses flowchart of cardiac disease in pregnancy.
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women undertook genetic testing as early as possible18 
to prevent giving birth to a child with congenital heart 
disease.21
Women desired to take control and live a ‘normal 
life’,20 24 participate in social activities and ‘fit in’.21 This 
often stemmed from childhood experiences of being 
excluded and ‘feeling different’.21 For some women, 
this motivated them to make their own decisions and to 
take on new and different activities as a means of coping: 
‘I do these things just to challenge those boundaries, 
limitations’.19
A lack of control
In contrast, a lack of autonomy and control was noted by 
women in relation to pregnancy decision-making. Some 
women believed that someone else would decide whether 
they should become pregnant in response to being ‘told 
right from the beginning not to have any more chil-
dren’.22 Another woman felt that she had no choice and 
could not take the risk and have her family shoulder the 
burden of another episode of heart failure.21 Others 
described feeling how social pressure and the judgement 
of others interfered with their decision to have more chil-
dren: ‘you're not supposed to get pregnant when you have 
congenital heart disease’.21 Another woman, who already 
had a child diagnosed with heart condition, feared being 
perceived as ‘selfish’.18
For some of the women, their heart disease defined and 
dominated their decision-making.18 One woman talked 
of how everything in her life ‘came down to the heart’.21 
While another described the tension the control of their 
disease had over them, and their own autonomy to make 
decisions, including those about pregnancy: ‘I do make 
plans and that sort of thing, but I don’t dare to carry them 
out. Now I understand that …I must start something inde-
pendently …but I’m scared’.19 A lack of autonomy and 
control was discussed by women in relation to financial 
hardship. Some women said that they had registered 
for disability payments after their diagnosis and were 
concerned that they would not be able to work after 
giving birth and contribute to the household income due 
to the impact the pregnancy would have on their phys-
ical and mental health. As a result, these women felt they 
would be financially dependent on others.22
The emotional uncertainty of decision-making
In three studies, women described the emotional uncer-
tainty of their preconception decision-making in highly 
emotional terms, where they were at a loss regarding what 
to do.18 19 One women asked ‘Is it worth it having a baby?’.28 
Women expressed feelings of being depressed and devas-
tated, and experiencing ‘emotional torture’ and feeling 
‘hysterical’ when they were diagnosed with cardiac 
disease and advised by their doctors against future preg-
nancies.22 These circumstances required them to rethink 
their situation.22 Several women described the decisions 
regarding pregnancy and childbirth as extremely difficult 
for them18 due to uncertainty regarding the progression 
and prognosis of their disease.19
Helplessness, fear and vulnerability
The feeling of helplessness and loss of control in relation 
to the development of cardiac disease symptoms both 
during pregnancy, birth and postpartum was expressed 
by one woman as like ‘being caught in a spider web’,28 or 
being trapped by their condition and fearful about future 
pregnancies.20 Another woman described being pregnant 
as a ‘constant struggle between hope and helplessness’.28 
There was a mix of physical and emotional symptoms 
when women described the suffering of their own illness 
and the inability to take care of their newborn baby.22 23
Women feared dying. They were deeply concerned that 
they would not survive the pregnancy and that they would 
leave their child motherless,21 24 25 or be left disabled and 
unable to care for their newborn.24 They were worried 
about passing on heart disease to their unborn baby,18 24 
giving birth to a baby with a heart abnormality21 24 and the 
effect that medications might have on their baby.21 These 
fears deeply affected women and some continued to 
relive the distress brought on by the diagnosis of cardiac 
disease in pregnancy through flashbacks, years after the 
birth of their child.23
self-care and risk awareness in pregnancy
Risk awareness and desire for motherhood were discussed 
in four of the papers.18 24 25 27 In a study by Andersen et 
al,18 women with long QT syndrome reported being frus-
trated not to know how much danger to their health a 
pregnancy might impose. They felt that if they took the 
risk to become pregnant, the decision was theirs.
For another group of women with congenital heart 
disease, the determination to have a child was so strong 
that it outweighed self-care considerations. Despite being 
aware of the complications during pregnancy, 10 of the 
20 women in the study perceived their disease to be less 
Table 1 Inclusion and exclusion criteria used to identify 
publications that involved women with cardiac disease in 
pregnancy
Inclusion criteria Exclusion criteria
The experiences of women of 
reproductive age with existing 
or acquired cardiac disease 
in pregnancy who were or 
had been pregnant, or who 
had contemplated pregnancy 
(including preconception, 
and prenatal, intrapartum, 
perinatal and postnatal 
periods)
Women with cardiac disease 
who were not of reproductive 
age or who had not been or 
contemplated pregnancy
Qualitative studies Quantitative studies
Mixed methods design with a 
qualitative component
Clinical studies of cardiac 
disease in pregnancy
Published in the English 
language
Non-English articles
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Table 2 Summary of the methodology and data of the 11 publications used in this review
Publication Method Aim Findings
Andersen et al,18 
2008
Qualitative: in-depth, 
face-to-face interviews
 ► To investigate psychosocial 
aspects of living with long QT 
syndrome (LQTS)
 ► To identify the daily challenges and 
coping strategies of LQTS patients
 ► To describe the experience of LQTS 
patients with healthcare services
 ► LQTS patients were concerned that 
the condition would be inherited by 
their children and grandchildren.
 ► LQTS patients favoured early genetic 
testing for LGTS, and the provision of 
information about LQTS in children 
presented early and gradually.
Claessens et 
al,19 2005
Qualitative: 
unstructured, in-depth 
interviews
 ► To explore the lived experiences of 
adult patients with congenital heart 
disease
 ► The central theme of the patients’ 
lived experiences was ‘feeling 
different’. Patients struggled 
constantly with themselves and with 
their environment to be accepted as 
normal.
Dekker et al,22 
2016
Publicly available 
narratives from three 
online support groups
 ► To describe the experience of 
women diagnosed with peripartum 
cardiomyopathy (PPCM)
 ► Nearly 40% of women felt that 
they were dismissed by healthcare 
providers. Women had difficulty 
caring for their newborns during the 
postnatal period, and they struggled 
with the medical advice they received 
to not conceive again.
Gantt,21 1992 Qualitative: 
unstructured face-
to-face interviews; 
grounded theory
 ► To generate an understanding of, 
and theories about, the lives of 
women with congenital heart disease
 ► Lack of information related to 
women’s bodies and reproductive 
issues (‘growing up female’).
 ► Over involvement of mothers and 
healthcare professionals in the affairs 
of the child's and woman's body, 
resulting in decreased ownership 
of the body by the woman (‘living 
against the body’).
 ► Poor self-esteem, self-concept and 
body image (‘growing up heartsick’).
 ► A need for various types of 
counselling for women with 
congenital heart disease was 
identified.
Gantt,20 2002 Qualitative: descriptive 
with unstructured 
interviews
 ► To study the effect of congenital 
heart diseases on the mother–
daughter relationship
 ► Over-riding theme of the study was 
normalising in the face of chronic 
illness, with a tendency by the 
mothers and daughters to focus on 
their lives instead of their relationship 
with one another.
Hess et al,26 2010 Descriptive: a survey of 
open-ended and Likert-
type questions
 ► To determine the benefits 
of participation in the online 
support group for peripartum 
cardiomyopathy, based on a survey 
of active members of the group
 ► One of the most important issues 
facing women with peripartum 
cardiomyopathy is future 
childbearing.
 ► The benefits of participation in 
the online support group included 
obtaining and sharing information, 
exchanging stories, being understood 
by other women and reassurance.
Hess et al,27 2012 Mixed method: analysis 
of social media 
postings made by 156 
people
 ► To describe the contents of postings 
made on the My Space peripartum 
cardiomyopathy support group 
website by women with peripartum 
cardiomyopathy
 ► The subject of pregnancy subsequent 
to the diagnosis of peripartum 
cardiomyopathy was mentioned 102 
times (among 247 posts), making 
it an issue that was foremost in the 
minds of many women.
Continued
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severe than that reported by their clinicians. These women 
therefore downplayed the seriousness of their condition 
that was found to be related to a reliance on the care of 
their health professionals, and a belief that medical and 
surgical care would result in a successful pregnancy and 
birth outcome. This distorted view of their condition 
was also linked to their quality of life which they felt was 
good.24
social support for decision-making
A feeling of empowerment and hope provided through 
social support was clearly demonstrated in several publi-
cations analysed in this study. Women using an online 
support said, ‘It is beneficial to know that you are not 
alone’,26 ‘friendly, open arms’ that ‘gave me hope’26 and 
‘there is always hope’.27 Some women shared the posi-
tive feeling of being able to talk to someone who could 
understand them without judgement and to share experi-
ences. Women found peer education to be an important 
part of managing their life and living with heart failure.26 
Another woman described the distress of having to face 
her pregnancy decision-making alone, as she lacked 
support from her family, who did not want her to take 
any risks.18
healthcare experiences
Health information needs
Our study revealed gaps in the understanding of women’s 
health information knowledge or needs by clinicians. 
Several women felt that they had received inadequate 
information from clinicians. Only six of the participants 
in one study had information about contraception and its 
relationship to their heart disease.21 One woman stated 
that she was ‘shocked’ that none of her clinicians had 
discussed the severity of her condition with her: ‘I thought 
I was completely fine. I didn’t know I wasn’t supposed to 
have any more kids’.26 The need for appropriate infor-
mation delivery and counselling was highlighted by one 
women who recounted the time of extreme panic when 
her doctor delivered her diagnosis: ‘With no family 
present, he told me that I might need a heart transplant 
and that I was finished being pregnant’.22
Responsive care
Many women felt that they had received supportive care 
from their healthcare team, were grateful and praised 
the skills and responsiveness of their clinicians. One 
woman expressed this by stating that the ‘world's elite 
team was there for me during the labour’.23 Another 
group of 13 women shared how grateful they were to the 
nurses who brought their newborn babies to the inten-
sive care unit where they were staying, and recognised 
the separation concerns.22 Women also reported feeling 
‘secure’ when provided with the phone number of a 
cardiac nurse or cardiologist to call if they were worried 
or had questions. Women valued check-ups as these 
gave them ‘hope’.23 Women trusted their clinicians and 
Publication Method Aim Findings
Ngu et al,25 2014 Mixed method: 
retrospective and 
descriptive
 ► To assess the perceptions of women 
with congenital heart disease 
regarding the severity of their cardiac 
abnormality and its implications 
in pregnancy, and whether their 
motivations to conceive were 
similar to those of women without 
congenital heart disease
 ► The personal experience of women, 
who successfully lived with their heart 
condition, influenced their perception 
of the pregnancy risks.
 ► Women with congenital heart disease 
were concerned about the health 
risks associated with their congenital 
heart disease and that of their child.
Ngu et al,24 2014 Mixed method: case 
studies
 ► To understand the motivations of 
women with congenital heart disease 
to bear children, and to assess if 
there were any differences between 
the cohort with low-risk and those 
with high-risk heart disease
 ► Women with high-risk (moderate 
to severe) congenital heart disease 
appeared to have similar motivations 
for conceiving as women with low-
risk (mild) congenital heart disease. 
Their drive for motherhood appeared 
to be stronger than their drive for 
self-care.
Patel, Berg et al,28 
2016
Mixed method: 
qualitative face-to-
face and telephone 
interviews; review of 
medical records
 ► To explore and describe the 
experiences of symptoms in 
peripartum cardiomyopathy in 
women
 ► A sense of being caught in a spider 
web consisting of the invasion of the 
body by experienced symptoms and 
a feeling of helplessness.
Patel, 
Schaufelberge et 
al,23 2016
Qualitative: 
unstructured interviews
 ► To explore the healthcare experience 
of women during their diagnosis with 
peripartum cardiomyopathy
 ► The main theme was ‘Exacerbated 
Suffering’ expressed in three 
subthemes: ‘not being cared about’, 
‘not being cared for’ and ‘not feeling 
secure’.
Table 2 Continued 
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perceived them to be compassionate professionals who 
would carefully monitor and support them throughout 
their pregnancy.24
Listening to women
Women commented on situations where clinicians had 
overly relied on the results of objective tests and careful 
monitoring throughout their pregnancy to manage their 
healthcare, rather than listening to them and taking their 
experiences and feelings into consideration.23 Some 
women reported that their voices were dismissed: ‘they 
didn’t seem to care’,22 ‘they did not listen to me’ and ‘did 
not respect my wish.’.23 As a result, women felt ignored, 
or misjudged, which caused sadness, insecurity and disap-
pointment in the service provided by their healthcare 
professionals. Women expressed feeling rejected by clini-
cians and felt that they were treated ‘like a drug addict’, 
‘like a pile of garbage’,23 ‘like a baby’.21 One woman 
suggested that clinicians learn more about the symp-
toms of their condition and take the complaints of their 
patients seriously.26
Healthcare facilities and professionals
There was a paucity of information in the literature 
regarding the healthcare centres and the specialist skills 
of their providers to support the needs of women with 
heart diseases. In Australia, women with congenital 
heart disease were reported to have received care from 
cardiologists in a public tertiary hospital24 and in private 
clinics25; in south eastern USA, they received care at a 
large tertiary care centre21; and in Norway, they received 
care at a university hospital.18 Women with congenital 
heart disease had also been recruited through an audit 
of records at a hospital department of paediatric and 
congenital cardiology in Belgium19 and in another US 
study, by private paediatricians.20 Women only referred 
to care they had received from both cardiologists and 
obstetricians in the Australian studies. Although women 
in the American and Norwegian studies referred gener-
ically to their ‘doctors’ or ‘health providers’ and nurses 
were noted in the paper from Belgium, less informa-
tion was available regarding the health facilities and 
providers of women with other acquired heart disease 
from the USA22 26 27 and Sweden.23 28 However, women 
in all studies, except in Hess et al,27 referred to cardiol-
ogists, obstetricians, nurses,22 23 midwives23 28 and emer-
gency department staff23 27 as their healthcare providers. 
It is difficult to draw conclusions from the findings of this 
study concerning the different healthcare experiences 
of women according to their providers and the facilities 
where they received care. While women with acquired 
heart disease were more likely to mention the care of 
cardiologists and obstetricians, as well as describe being 
listened to by their providers, such descriptions were not 
available in the corresponding papers that described 
women with congenital heart disease.24 25
dIsCussIOn
This paper reports the first metasynthesis of qualitative 
research that investigated the experiences of pregnant 
women with a spectrum of cardiac disease. It provided 
insight into the continuum of preconception, pregnancy 
and parenting decision-making of these women and 
provided evidence to inform new healthcare practices 
and communication for cardiac care in women with heart 
disease. Our research shows the struggle women have with 
gaining autonomy and control over their decision-making 
during pregnancy, and how this impacts their daily lives 
and presents challenges to self-care during pregnancy. 
The level of autonomy and control was the most preva-
lent theme that came across all cardiac conditions investi-
gated reflecting the need for women-centred care.
Our approach did not enable pooling of results and 
comparison of data across studies. However, our analysis 
explained how the studies were related, or dissonant, 
and compared coding and themes (see table 4). This 
enabled patterns to be discerned that could be translated 
into cardiac disease in pregnancy and potentially other 
rare and chronic diseases in pregnancy. It is possible that 
our thematic analysis may have led to a loss of detail, 
particularly in relation to the unique contexts of women 
lives; however, efforts were made to maintain this in the 
descriptive part of the analysis to retain the integrity of 
the original studies. The exclusion of non-English papers 
may have resulted in an incomplete retrieval of research 
studies.
Women’s autonomy and control
In five of the studies in our metasynthesis, women iden-
tified a lack of understanding of and attention to their 
existing knowledge by clinicians, as well as their self-re-
ported health status and health needs as barriers to satis-
factory care.21–23 26 27 While suggestions were made about 
how shared decision-making could be implemented into 
cardiovascular care,29 30 and translated into practice in to 
national programmes such as the Million Hearts initia-
tive,31 32 a gendered approach was not considered nor 
examined in the unique context of various cardiac condi-
tions in pregnancy.
Clinicians could be better supported to facilitate a 
woman’s active role in decision-making at the point of 
care by using tailored tools, particularly where a woman’s 
self-care may be affected by downplaying their cardiac 
disease as found in two studies in the metasynthesis.24 25 
In these cases, gendered tools that incorporate collabora-
tive deliberation33 or conversations between women and 
clinicians could have been useful.
Elwyn et al’s ‘Talk model’34 provides a useful concep-
tual framework for shared decision-making that enables 
measurement across four components to facilitate effec-
tive communication and its ongoing evaluation between 
a woman and her clinician. However, women also have 
a responsibility to contribute to charting a clear path 
through decision-making by identifying barriers and solu-
tions to their implementation.35 Even though the Elwyn 
 o
n
 10 O
ctober 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-022755 on 28 September 2018. Downloaded from 
10 Dawson AJ, et al. BMJ Open 2018;8:e022755. doi:10.1136/bmjopen-2018-022755
Open access 
talk model provides a practical way forward for clinicians 
and women, it does not consider the steps or processes 
required for implementation including buy-in at the indi-
vidual clinician and practice level through guidelines and 
consensus statements, integration into the workflow and 
evaluation,29 particularly in the context of cardiac disease 
in pregnancy.12
Although the voices of pregnant women with genetic 
conditions and/or from low, lower-middle and upper-mid-
dle-income countries as per the World Bank Atlas defi-
nition36 were absent from the literature, it is likely that 
they, too, would struggle to gain autonomy and control 
over their decision-making and to manage their fears and 
vulnerabilities for all cardiac conditions.
self-care and risk awareness in pregnancy
Consistent with previously published reports,37–40 our 
study revealed little insight into preconception coun-
selling and the advice clinicians provided concerning 
contraception for women with existing cardiac disease or 
after a pregnancy, when cardiac disease was diagnosed. In 
one study, less than 50% of women with cardiac disease 
had received any counselling.39 We found that the timing 
of a woman’s diagnosis of cardiac disease, and hence her 
experience, was different depending on the type of heart 
condition. Most of those with congenital heart disease 
would have been expected to have knowledge of their 
conditions, and ideally would have had preconception 
counselling. However, for those with PPCM, the diagnosis 
may have occurred late in the pregnancy, meaning that 
some women would have entered pregnancy without 
cardiac disease and experienced a very different preg-
nancy until diagnosed. However, many women with PPCM 
present postpartum,41 and therefore, these women’s 
counselling needs would take into consideration subse-
quent pregnancies.
Miner et al emphasised the importance of including 
contraceptive counselling early in adolescence on an 
‘on-going basis’.38 Furthermore, the American Heart Asso-
ciation and others provide recommendations regarding 
prenatal counselling for women and their families with 
heart disease, as well as counselling in relation to the 
expectant child that takes into consideration feeding and 
growth issues, quality of life and long-term care, family 
stressors and foetal cardiac interventions.12 42
social support for decision-making
The health benefits of social support for pregnant women 
from their partner, family, friends and those who have 
experienced similar circumstances are well known43 and 
a significant predictor of health-related quality of life. 
Other authors have highlighted the importance of peer 
mentoring for pregnant women with defined health 
needs to allay fear and anxiety, particularly for women with 
spinal cord injuries44 45 and patients with cardiovascular 
disease.46 Women in two papers in our study26 27 found 
that online blogs related to their disease were helpful. 
Other studies found online forums to be supportive 
for other pregnant women with rare or life-threatening 
conditions in pregnancy.47
healthcare experiences
Decision-making tools for healthcare can increase patient 
participation and improve accurate risk perceptions.48 49 
For women with heart disease, our recommendation is 
that women should be engaged in the design of these 
decision-making tools in consultation with health-
care providers and that an effective communications 
strategy is implemented that links the opinions of cardi-
ologists, obstetricians, maternal foetal medicine special-
ists, obstetric physicians and anaesthetists, intensivists, 
midwives and cardiac nurses50 to optimise patient care. 
This strategy would provide a comprehensive support 
tool that would console women, allay their fears and build 
their confidence and resilience through coping and self-
care strategies. Supporting this approach are data from 
a study by Patel et al who reported that effective commu-
nication led to responsive and tailored care in women 
who received high-quality care from teams of health 
professionals.23
The American Heart Association emphasises the impor-
tance of measuring the self-reported health status (ie, 
symptom burden, functional status, and health-related 
quality of life) of patients with cardiac disease as it is not 
only a necessary component of clinical risk scoring, but 
consistent with a holistic view of health and the goals of 
patient-centred care.51
COnClusIOn
Our metasynthesis revealed that there is a need for 
tailored, responsive care and gendered models to guide 
shared decision-making and empathetic counselling 
across the reproductive lifespan for women with cardiac 
disease. Our findings were consistent with the experiences 
of women with other non-communicable diseases in preg-
nancy, such as chronic kidney disease and diabetes52 53 and 
similar to studies of non-pregnant women with cardiac 
disease.54 55 Our study identified opportunities to improve 
shared decision-making whereby clinicians understand 
the social context (her family, employment and other 
responsibilities) of women and their goals, values and 
preferences for health. Shared decision-making can facil-
itate effective communication between a woman and 
her clinician to develop a shared understanding of the 
problem and generate a mutually acceptable evaluation 
and management plan.
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